Prosthetic Heart Valve Industry to Reach USD 27,277.6 Million by 2033 at a 7.5% of CAGR, Driven by Rising Prevalence of Valvular Diseases

The global prosthetic heart valve market is poised for significant growth, with a projected valuation of US$ 13,234.9 million in 2023, expected to more than double to US$ 27,277.6 million by 2033, according to the latest market analysis. This growth trajectory reflects a robust Compound Annual Growth Rate (CAGR) of 7.5% over the forecast period. …

Coronary Stents Industry Set for Exponential Growth Driven by Rising Cardiovascular Cases and Minimally Invasive Solutions

According to the latest analysis by Future Market Insights (FMI), the demand for coronary stents, including portable variants, is expected to rise significantly in the coming years. Key factors driving this growth include the aging population and an increasing prevalence of cardiovascular diseases (CVDs), diabetes, obesity, and complex lesions. These risk factors underscore the critical …

PET Scanner Industry to Surpass USD 2.1 Billion by 2033 at a 5.3% of CAGR, Driven by Rising Disease Prevalence and Technological Advancements

The global positron emission tomography (PET) scanners market is projected to grow significantly over the next decade, increasing from an estimated USD 1.3 billion in 2023 to USD 2.1 billion by 2033, according to the latest market analysis. This growth represents a robust Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period. The …

GCC Medical Glove Industry to Reach USD 213.7 Million by 2034 at a 2.3% of CAGR, Amid Rising Focus on Hygiene Practices

The GCC medical glove industry is poised for steady growth, with an estimated market value of US$ 170.3 million in 2024, according to a recently updated industry analysis report. The heightened focus on maintaining stringent hygiene standards in healthcare settings across the Gulf Cooperation Council (GCC) region is anticipated to be a primary driver of …

Hypercalcemia Treatment Industry to Triple in Value by 2033, Reaching USD 55.07 Billion at a 11.8% of CAGR

The global market for hypercalcemia treatment is poised for substantial growth, with a valuation of USD 18.07 billion in 2023. Exhibiting a remarkable CAGR of 11.8% over the forecast period (2023–2033), the market is projected to reach an impressive valuation of USD 55.07 billion by 2033. Key Growth Factors: Rising Incidence of Hypercalcemia The increasing …

GCC Syringes and Needles Industry Set for Robust Growth, Projected to Reach USD 1,164.90 Million by 2034 at a 5.40% of CAGR

The market for syringes and needles in the GCC (Gulf Cooperation Council) region is expected to experience steady growth over the coming decade, driven by advancements in healthcare infrastructure, increasing prevalence of chronic diseases, and growing demand for modern medical devices. Sales of syringes and needles in GCC are projected to grow at a CAGR …

Global Antibody Discovery Market Valuation Set to Total USD 21.8 Billion by 2034, Spurred by Escalating Demand for Targeted Therapies | FMI

As per Future Market Insights’ latest analysis, the global antibody discovery market value is forecast to total USD 8.5 billion in 2024. Over the next decade, global antibody discovery demand will increase at around 9.9% CAGR, taking the total market valuation to USD 21.8 billion by 2034. This demonstrates the growing importance of antibodies in …

Global Veterinary Telehealth Market is set to expand at a 17.7% CAGR by 2034 to reach USD 970 Million | Future Market Insights

The global veterinary telehealth market is anticipated to be valued at USD 190.8 million by 2024. The market valuation is estimated to be USD 970 million by 2034, projected at a CAGR of 17.7%. The surge in the need for easily accessible and convenient pet care solutions is one of the major factors impelling the …

Global Large Volume Wearable Injectors Market Set for Remarkable Growth, Projected to Reach USD 7,142.3 Million by 2032

The global large volume wearable injectors market is poised for remarkable growth, with forecasts predicting a leap from USD 2,800.0 million in 2022 to an impressive USD 7,142.3 million by 2032. This expansion reflects a robust Compound Annual Growth Rate (CAGR) of 8.9%, underscoring a pivotal shift in the healthcare landscape toward home-based care solutions. …

Global Inflammatory Bowel Disease Treatment Market Poised for Significant Growth, Projected to Reach USD 35.1 Billion by 2032

The global inflammatory bowel disease (IBD) treatment market, valued at approximately USD 20.2 billion in 2022, is set for substantial growth over the next decade. According to new projections, the market is expected to expand at a remarkable Compound Annual Growth Rate (CAGR) of 5.7%, reaching an estimated value of USD 35.1 billion by the …